Literature DB >> 16239668

Cervical cancer, human papillomavirus, and vaccination.

Catherine M Lowndes, O Noel Gill.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16239668      PMCID： PMC1261173          DOI： 10.1136/bmj.331.7522.915

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  10 in total

1.  The cervical cancer epidemic that screening has prevented in the UK.

Authors:  Julian Peto; Clare Gilham; Olivia Fletcher; Fiona E Matthews
Journal:  Lancet       Date:  2004 Jul 17-23       Impact factor: 79.321

2.  WHO consultation on human papillomavirus vaccines.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2005-09-02

Review 3.  The causal relation between human papillomavirus and cervical cancer.

Authors:  F X Bosch; A Lorincz; N Muñoz; C J L M Meijer; K V Shah
Journal:  J Clin Pathol       Date:  2002-04       Impact factor: 3.411

4.  Sexual behaviour in Britain: partnerships, practices, and HIV risk behaviours.

Authors:  A M Johnson; C H Mercer; B Erens; A J Copas; S McManus; K Wellings; K A Fenton; C Korovessis; W Macdowall; K Nanchahal; S Purdon; J Field
Journal:  Lancet       Date:  2001-12-01       Impact factor: 79.321

5.  Global cancer statistics, 2002.

Authors:  D Max Parkin; Freddie Bray; J Ferlay; Paola Pisani
Journal:  CA Cancer J Clin       Date:  2005 Mar-Apr       Impact factor: 508.702

6.  Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial.

Authors:  Luisa L Villa; Ronaldo L R Costa; Carlos A Petta; Rosires P Andrade; Kevin A Ault; Anna R Giuliano; Cosette M Wheeler; Laura A Koutsky; Christian Malm; Matti Lehtinen; Finn Egil Skjeldestad; Sven-Eric Olsson; Margareta Steinwall; Darron R Brown; Robert J Kurman; Brigitte M Ronnett; Mark H Stoler; Alex Ferenczy; Diane M Harper; Gretchen M Tamms; Jimmy Yu; Lisa Lupinacci; Radha Railkar; Frank J Taddeo; Kathrin U Jansen; Mark T Esser; Heather L Sings; Alfred J Saah; Eliav Barr
Journal:  Lancet Oncol       Date:  2005-05       Impact factor: 41.316

7.  Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis.

Authors:  G M Clifford; S Gallus; R Herrero; N Muñoz; P J F Snijders; S Vaccarella; P T H Anh; C Ferreccio; N T Hieu; E Matos; M Molano; R Rajkumar; G Ronco; S de Sanjosé; H R Shin; S Sukvirach; J O Thomas; S Tunsakul; C J L M Meijer; S Franceschi
Journal:  Lancet       Date:  2005 Sep 17-23       Impact factor: 79.321

8.  Epidemiologic classification of human papillomavirus types associated with cervical cancer.

Authors:  Nubia Muñoz; F Xavier Bosch; Silvia de Sanjosé; Rolando Herrero; Xavier Castellsagué; Keerti V Shah; Peter J F Snijders; Chris J L M Meijer
Journal:  N Engl J Med       Date:  2003-02-06       Impact factor: 91.245

9.  A controlled trial of a human papillomavirus type 16 vaccine.

Authors:  Laura A Koutsky; Kevin A Ault; Cosette M Wheeler; Darron R Brown; Eliav Barr; Frances B Alvarez; Lisa M Chiacchierini; Kathrin U Jansen
Journal:  N Engl J Med       Date:  2002-11-21       Impact factor: 91.245

10.  Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial.

Authors:  Diane M Harper; Eduardo L Franco; Cosette Wheeler; Daron G Ferris; David Jenkins; Anne Schuind; Toufik Zahaf; Bruce Innis; Paulo Naud; Newton S De Carvalho; Cecilia M Roteli-Martins; Julio Teixeira; Mark M Blatter; Abner P Korn; Wim Quint; Gary Dubin
Journal:  Lancet       Date:  2004 Nov 13-19       Impact factor: 79.321
  10 in total
  9 in total

1.  Details of HPV immunisation need not delay decision.

Authors:  Adam Finn
Journal:  BMJ       Date:  2005-11-05

2.  HPV vaccine and adolescents' sexual activity.

Authors:  Bernard Lo
Journal:  BMJ       Date:  2006-05-13

Review 3.  An armamentarium of wart treatments.

Authors:  Michelle M Lipke
Journal:  Clin Med Res       Date:  2006-12

4.  Ensuring access to HPV vaccines through integrated services: a reproductive health perspective.

Authors:  Amy E Pollack; Miranda Balkin; Lindsay Edouard; Felicity Cutts; Nathalie Broutet
Journal:  Bull World Health Organ       Date:  2007-01       Impact factor: 9.408

5.  Strategies for the introduction of human papillomavirus vaccination: modelling the optimum age- and sex-specific pattern of vaccination in Finland.

Authors:  K M French; R V Barnabas; M Lehtinen; O Kontula; E Pukkala; J Dillner; G P Garnett
Journal:  Br J Cancer       Date:  2007-01-23       Impact factor: 7.640

6.  Infection and disease: cause and cure.

Authors:  C Simon Herrington; Daniel C Douek
Journal:  J Pathol       Date:  2006-01       Impact factor: 7.996

7.  Vaccines against human papilloma virus and cervical cancer: an overview.

Authors:  Savita Sharma
Journal:  Indian J Community Med       Date:  2008-07

8.  Public knowledge and attitudes towards Human Papilloma Virus (HPV) vaccination.

Authors:  Charlotte Devereaux Walsh; Aradhana Gera; Meeraj Shah; Amit Sharma; Judy E Powell; Sue Wilson
Journal:  BMC Public Health       Date:  2008-10-23       Impact factor: 3.295

9.  Brachytherapy for cervix cancer: low-dose rate or high-dose rate brachytherapy - a meta-analysis of clinical trials.

Authors:  Gustavo A Viani; Gustavo B Manta; Eduardo J Stefano; Ligia I de Fendi
Journal:  J Exp Clin Cancer Res       Date:  2009-04-05
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.